{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:17:29Z","timestamp":1783099049155,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xcrm.2026.102648","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:15:27Z","timestamp":1773760527000},"page":"102648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of tofersen PD-response biomarkers in VALOR clinical trial CSF via multiplexed quantitative proteomics"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-9373","authenticated-orcid":false,"given":"Amanda J.","family":"Guise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle L.","family":"Ferber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Sabouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle B.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Milliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Plowey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Zoghbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Fradette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102648_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102648_bib2","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/hmg\/ddp260","article-title":"Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease","volume":"18","author":"Prudencio","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2026.102648_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ana.21356","article-title":"Inclusions of amyotrophic lateral sclerosis-linked superoxide dismutase in ventral horns, liver, and kidney","volume":"63","author":"Jonsson","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102648_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1534\/g3.118.200787","article-title":"Experimental mutations in superoxide dismutase 1 provide insight into potential mechanisms involved in aberrant aggregation in familial amyotrophic lateral sclerosis","volume":"9","author":"Crown","year":"2019","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.xcrm.2026.102648_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21543","article-title":"Current hypotheses for the underlying biology of amyotrophic lateral sclerosis","volume":"65","author":"Rothstein","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102648_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac029","article-title":"Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain","volume":"4","author":"Thompson","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.xcrm.2026.102648_bib7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102648_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-019-02093-x","article-title":"Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis","volume":"139","author":"Oeckl","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2026.102648_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12031-019-01411-y","article-title":"Targeted multiple reaction monitoring analysis of CSF identifies UCHL1 and GPNMB as candidate biomarkers for ALS","volume":"69","author":"Zhu","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102648_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/srep00573","article-title":"The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis","volume":"2","author":"Tanaka","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102648_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-018-1100-1","article-title":"The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor","volume":"15","author":"Neal","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102648_bib12","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/jnr.23999","article-title":"GPNMB ameliorates mutant TDP-43-induced motor neuron cell death","volume":"95","author":"Nagahara","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.xcrm.2026.102648_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102648_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5582\/irdr.2019.01049","article-title":"Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease","volume":"8","author":"Satoh","year":"2019","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.xcrm.2026.102648_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010066","article-title":"Glycoprotein non-metastatic protein B: an emerging biomarker for lysosomal dysfunction in macrophages","volume":"20","author":"van der Lienden","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.102648_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0192623314551840","article-title":"Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective","volume":"43","author":"Frazier","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.xcrm.2026.102648_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jimd.12251","article-title":"Opportunities and challenges for antisense oligonucleotide therapies","volume":"44","author":"Kuijper","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.xcrm.2026.102648_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-025-00466-9","article-title":"Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington's disease","volume":"14","author":"Ou","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.xcrm.2026.102648_bib19","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4155\/bio-2019-0133","article-title":"Immunogenicity for antisense oligonucleotides: a risk-based assessment","volume":"11","author":"Stebbins","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.xcrm.2026.102648_bib20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/mus.28372","article-title":"Serious neurologic adverse events in tofersen clinical trials for amyotrophic lateral sclerosis","volume":"71","author":"Lovett","year":"2025","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.xcrm.2026.102648_bib21","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/ana.70025","article-title":"Targeted proteomics upon treatment with tofersen identifies novel response markers for superoxide dismutase 1-linked amyotrophic lateral sclerosis","volume":"98","author":"Steffke","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102648_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00702-021-02411-2","article-title":"Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration","volume":"129","author":"Gomez de San Jose","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.xcrm.2026.102648_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000516752","article-title":"Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants","volume":"55","author":"Brown","year":"2021","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.xcrm.2026.102648_bib26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","article-title":"An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database","volume":"5","author":"Eng","year":"1994","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.xcrm.2026.102648_bib27","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/rcm.1290091515","article-title":"Direct database searching with MALDI-PSD spectra of peptides","volume":"9","author":"Griffin","year":"1995","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.xcrm.2026.102648_bib28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1044-0305(96)00079-7","article-title":"Search of sequence databases with uninterpreted high-energy collision-induced dissociation spectra of peptides","volume":"7","author":"Yates","year":"1996","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.xcrm.2026.102648_bib33","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102648_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-3341-9_1","article-title":"Multiplexed quantitative proteomics for high-throughput comprehensive proteome comparisons of human cell lines","volume":"1394","author":"Edwards","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.102648_bib25","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1021\/ac502040v","article-title":"MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes","volume":"86","author":"McAlister","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.xcrm.2026.102648_bib29","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1021\/pr800420s","article-title":"A fast SEQUEST cross correlation algorithm","volume":"7","author":"Eng","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.xcrm.2026.102648_bib30","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1016\/j.molcel.2021.09.015","article-title":"Proteome-wide mapping of short-lived proteins in human cells","volume":"81","author":"Li","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102648_bib31","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.cell.2010.12.001","article-title":"A tissue-specific atlas of mouse protein phosphorylation and expression","volume":"143","author":"Huttlin","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102648_bib32","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1074\/mcp.M114.046995","article-title":"A scalable approach for protein false discovery rate estimation in large proteomic data sets","volume":"14","author":"Savitski","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.xcrm.2026.102648_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"2018","journal-title":"J. Roy. Stat. Soc. B"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:24:38Z","timestamp":1783095878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666379126000650"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102648","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of tofersen PD-response biomarkers in VALOR clinical trial CSF via multiplexed quantitative proteomics","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102648"}}